Searched for
CADILA VACCINE
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Zydus Cadila's shot to be soon part of vaccine driveTo begin with, seven states including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar Pradesh and West Bengal will use the vaccine.
- Zydus Cadila's ZyCov-D shot to soon join other vaccines in India's Covid fightThe drug regulator had on August 20 given emergency use authorisation (EUA) to the three-dose Covid-19 vaccine, the first in India that can...
- Right pricing to hold the key for Zydus Cadila's vaccine launchZydus Cadila has the drug regulator's emergency use authorisation to administer its Covid vaccine, ZyCoV-D, in children aged 12-18 years. A...
- Government lab releases first batch of Zydus Cadila's covid vaccine ZyCoV-DNeedle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...
- India's Shilpa Medicare to make Cadila's COVID-19 vaccineThe country's health authorities had given emergency approval in August for Cadila's vaccine, the world's first COVID-19 DNA shot, in adult...
- Talks on to make Zydus Cadila's COVID-19 DNA vaccine part of inoculation programme: GovtZydus Cadila's indigenously-developed needle-free COVID-19 vaccine ZyCoV-D received the Emergency Use Authorisation from the Drugs Controll...
- Will three-dose Covid vaccine give Cadila Healthcare a booster shot?Analysts do see a lift to its sales, even as some of them are not factoring in sales beyond FY23 amid uncertainty over booster shots. The p...
- Hope to start supply of ZyCoV-D vaccine by mid to end September: Zydus Group MD"Post the emergency use authorisation, now we will work closely with the regulatory authorities to work on the pricing and modality of deli...
- Zydus Cadila likely to get emergency use approval for its COVID vaccine this week: SourcesZydus Cadila last month had said that it has applied for emergency use authorisation (EUA) with the Indian Drug regulator for its three-dos...
- Zydus Cadila's vaccine for kids above 12 to come up for approval this weekThe drug regulator will consider emergency use approval for Covid vaccines developed by Zydus Cadila for children above 12 this week. The r...
- ‘Cadila vaccine found to be safe for children aged 12-18 years’The Ahmedabad-based company is carrying out clinical trials involving 1,000 children to test the efficacy of its vaccine against SARS-CoV-2...
- India seems to be getting closer to an antidote, even as the coronavirus situation worsensThis week India overtook the US in daily addition of new COVID-19 cases. It is worrying. The World Health Organization says that the infect...
- Zydus Cadila aims to complete trial of coronavirus vaccine by March: Chairman Pankaj PatelCadila's vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic.
- Zydus and Pharm Aid Ltd. enter into an exclusive agreement for vaccine technology in RussiaThrough this agreement, Zydus gains access to the public and private market segments in the Russian Federation, Belarus, Uzbekistan, Kazakh...
- Cadila Pharma files for cancer vaccine patentCadila Pharmaceuticals has developed a cancer vaccine and has filed for its therapeutic patent with Controller General of Patents Designs a...
- Zydus Cadila gets DCGI nod to conduct trials for H1N1 vaccineDrug maker Zydus Cadila on Monday said it has received approval from the Drug Controller General of India (DCGI) for conducting clinical tr...
- Cadila forms JV with US-based vaccine major NovavaxAhmedabad-based Rs 800-crore Cadila Pharmaceuticals Ltd is all geared up for a large pie in the $665-million vaccine market in India.
- Novavax, Cadila form JV for developing vaccinesUS-based biotechnology firm Novavax has formed a joint venture with Cadila Pharmaceuticals for developing and commercialising virus-like pa...
Load More
